source
- Lisata Therapeutics merges with Marea Therapeutics in reverse merger after failed Kuva dealLisata Therapeutics, a solid tumor biotech, announced a stock-for-stock merger with cardiovascular specialist Marea Therapeutics after a previous merger attempt with Kuva Labs collapsed. The trans…
- Roche partners with Dualitas Therapeutics in up to $1 billion deal to screen bispecific antibodies for immune diseasesRoche has committed $36.5 million up front to biotechnology startup Dualitas Therapeutics under a research partnership that could total up to $1 billion in milestone payments and royalties. The agr…